Olaf Pharmaceuticals develops high quality extracellular matrix products for various purposes including cell attachment, cell growth, cell differentiation, cell migration, Stem cell research, tissue engineering and tissue morphogenesis. Olaf Pharmaceuticals is currently offering a range of Type I collagen products derived from various sources as well as various pharmaceutical products including Human Microvascular Endothelial Cells, Fluorescently-labeled Cells, Anti-Human and Anti-Mouse Antibodies, siRNA products, and stable shRNA transfected HUVECs.